Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
Price development of orphan drugs in Germany after market access and subsequent assessments: a descriptive analysis
C Balg1, K Frangen2, A C Brockhaus3
1Department of Health Economics, Institute for Quality and Efficiency in Health Care, Siegburger Str. 237, Cologne, 50679, Germany. Christiane.Balg@iqwig.de.
No abstract available in PubMed .
More Related Videos
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Clinical Trials: Overview
FDA Approved Drugs: Changes to Approved Drugs
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Preclinical Development: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions